|
Cynthia J. BurrowsORGANIC & BIOLOGICAL CHEMISTRYProfessor |
The heterocyclic bases of nucleic acids are rich targets for both toxins that damage DNA and drugs that interact with DNA and RNA. Our laboratory investigates several different aspects of nucleic acid chemistry ranging from the mechanistic organic chemistry of oxidative DNA damage to biochemical studies of enzymes that act on DNA lesions. Lessons learned in modified DNA bases are also being applied to the design of new siRNAs for applications to therapeutic RNA interference. Tools used in our lab include:
Chemistry and Biochemistry of Guanine Oxidation. Reactive oxygen species (ROS) in the cell lead to DNA damage including base lesions that are mutagenic if unrepaired. The molecular events leading to mutagenesis now provide a direct link between oxidative DNA damage and cancer. An understanding of the molecular basis of carcinogenesis is the foundation of prevention and treatment. The unusual heterocycles 5-guanidinohydantoin (Gh) and spiroiminodihydantoin (Sp), whose structures were recently assigned in this laboratory, are major products of guanosine and 8-oxo-7,8-dihydroguanosine (OG) oxidation by a wide variety of ROS including singlet oxygen and peroxyl radicals. We have investigated the chemical mechanism of formation of Gh and Sp, developed methods of generating highly pure synthetic oligodeoxynucleotides containing these lesions, studied misinsertion of nucleotides opposite the lesions as well as repair by base excision repair (BER) enzymes, and observed a 99% mutation rate of both lesions in an in vivo assay. The recent detection of Sp in repair-deficient bacterial cells increases the relevancy of these lesions to oxidative damage and disease.
Currently we seek to understand the molecular basis for the extremely high mutation rates and the unusual G to C mutations observed with Gh and Sp. Other oxidized purines, including OG, are under study for comparison. Specifically, we hope to determine the structures of Gh and Sp in duplex DNA using NMR and x-ray crystallographic techniques, examine misinsertion of nucleotides opposite the lesions with Y-family (lesion bypass) DNA polymerases and investigate sequence-dependent frameshift mutagenesis with eukaryotic polymerases. Structural studies involve collaborations with Prof. Mike Stone (Vanderbilt) and Prof. Sylvie Doublié (U. Vermont). In collaboration with Prof. Sheila David (UC, Davis) we are studying the molecular mechanisms of repair of Gh and Sp lesions using BER glycosylases, and with Prof. John Essigmann (MIT) we are investigating in vivo mutagenesis using site-specifically incorporated lesions in DNA plasmids. All of our research goals require continual refinement of our synthetic procedures for generation of nucleoside standards, nucleotide triphosphates and oligonucleotide substrates as well as mass spectrometric characterization of the lesions. This research is supported by a grant from the National Institutes of Health, 2R01 CA090689.
Mechanisms of DNA Oxidation and Cross-linking. DNA strand breaks, base lesions, and DNA-protein cross-links result from oxidative insult to chromatin. Although detailed mechanistic pathways are being elucidated for the first two of these processes in a number of laboratories, formation of DNA-protein cross-links (DPCs) remains poorly understood at the molecular level. Studies outlined in this proposal build upon recent results showing that 8-oxo-7,8-dihydroguanosine is sensitive to further oxidation by one-electron oxidants leading to a quinonoid intermediate that is nucleophilically trapped to ultimately generate hydantoin products. Experiments underway include NMR and LC/MS characterization of amino acid and polyamine adducts to nucleosides and to DNA oligomers, and investigation of their mechanisms of formation and chemical stability. Methods are being developed to understand the chemical structures responsible for DNA-protein cross-linking via both DNA oxidation and protein oxidation. Adducts of phenols and catechols to guanosine in DNA have been prepared and analyzed for their ability to mediate further oxidative damage to DNA. The intellectual merit of this work is the formation of a detailed molecular picture of how DNA is oxidized in the presence of reactive species such as protein and polyamine nucleophiles.
Students working on this project are well versed in mechanistic organic chemistry, and gain biotechnical skills in the manipulation of nucleic acids and proteins. Their overall contribution is to our molecular understanding of DNA damage which underlies processes leading to aging, cancer, and neurological disorders. This project is funded by the National Science Foundation, CHE-0514612.
Chemical Modifications of siRNA Bases. Selective nuclease digestion of messenger RNAs inside living cells via the short interfering RNA (siRNA)-triggered RNA interference pathway has become a mainstay in molecular biology to study gene function, and it holds promise for the development of new therapeutics. However, gaps in our understanding of the basic RNA interference mechanism and ability of siRNAs to interact with intracellular RNA-binding proteins, particularly those involved in the innate immune response, limit the application of this promising new technology. Our laboratory is developing new synthetic approaches to modified RNA oligonucleotides that carry out gene silencing with reduced undesirable off-target effects. Specifically, we are engaged in the study of alkylated RNA bases that change the shape of the minor or major groove of double-stranded RNA while maintaining Watson-Crick-like base pairing. These siRNA duplexes are being used to determine the effect of steric blocks in gene silencing. The modifications are also expected to block sequence-dependent off-target ettects mediated by Toll-like receptors and sequence-independent effects from dsRBM proteins.
Secondly, we are developing modified bases capable to switching their steric blockades from the minor groove to the major groove (see figure). These modifications will be placed in the antisense strand using a Watson-Crick-paired sense strand for delivery; the antisense strand will be designed to target a complementary mRNA sequence via Hoogsteen base pairing in which a conformational change hides the steric blockade in the major groove.
This project is being conducted in collaboration with Professor Peter Beal (UC, Davis) and is supported by the NIH, R01 GM080784.